References
Arredondo-García J-L, Ortiz-Ibarra FJ, Figueroa-Damian R, Valdes-Ramos R. Current concepts in acute purulent meningitis. Drug Investigation 4 (Suppl. 2): 18–25, 1992
de la Garza-Paez C, Cantu-Garza E, Lozano JA. Cefotaxime as prophylaxis of infections in open fractures. Drug Investigation 4 (Suppl. 2): 37–40, 1992
Jacobs RF. Corticosteroid adjunctive therapy for bacterial meningitis in infants and children. Drug Investigation 4 (Suppl. 2): 26–36, 1992
Kearns GL. Desacetylcefotaxime: clinical implications of an active metabolite in infants and children. Drug Investigation 4 (Suppl. 2): 9–17, 1992
Rodríguez-Noriega E, Morfin-Otero R, Atilano-Duran G, Rodríguez-Chagollan JJ, Esparza-Ahumada S. Bacterial resistance to antimicrobial agents in Mexico. Drug Investigation 4 (Suppl. 2): 2–8, 1992
Villazon-Sahagun A, Terrazas EF, Ranan R. Advances in the understanding and treatment of metabolic and organic failure in sepsis. Drug Investigation 4 (Suppl. 2): 41–48, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rodríguez-Noriega, E., Arredondo-García, JL. Introduction. Drug Invest 4 (Suppl 2), 1 (1992). https://doi.org/10.1007/BF03258350
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03258350